Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with graves' hyperthyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 4, 1999, Pages 1255-1262

  Gunji, Kazuaki ^a   De Bellis, Annamaria ^b   Kubota, Sumihisa ^a   Swanson, Jil ^a   Wengrowicz, Sylvia ^c   Cochran, Bruce ^d   Ackrell, Brian A C ^d   Salvi, Mario ^e   Bellastella, Antonio ^b   Bizzarro, Antonio ^b   Sinisi, Antonio A ^b   Wall, Jack R ^a,f  

^a ALLEGHENY UNIVERSITY HOSPITALS   (United States)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF PARMA MEDICAL SCHOOL   (Italy)

^f QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME ANTIBODY; PROTEIN SUBUNIT; SUCCINATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; CONNECTIVE TISSUE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRAOCULAR MUSCLE; EYE DISEASE; FEMALE; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; ORBIT; PRIORITY JOURNAL;

EID: 0033323817     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.4.1255     Document Type: Article

References (45)

1. Graves' ophthalmopathy: Current concepts regarding pathogenesis and management
2. Thyroid-associated eye disease: Pathophysiology
3. The ocular muscle is the target of the immune system in endocrine ophthalmopathy-pro
4. Human orbital tissue and thyroid membranes express a 64-kDa protein which is recognized by autoantibodies in the serum of patients with thyroid-associated ophthalmopathy
5. Significance of antibodies reactive with a 64-kDa eye muscle membrane antigen in patients with thyroid auto immunity
6. Identification of autoantigen recognized by autoimmune ophthalmopathy sera with immunoblotting correlated with orbital computed tomography
7. Significance of anti-eye muscle antibody in patients with thyroid-associated ophthalmopathy by quantitative Western blot
8. Serum eye muscle and TSH receptor antibodies predicted the development of ophthalmopathy in a euthyroid subject with a family history of autoimmunity
9. Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and nonthyroid disorders
10. New assays for the measurement of serum antibodies reactive with eye muscle membrane antigens confirms their importance in thyroid-associated ophthalmopathy
11. The 64-kDa eye muscle protein is the flavoprotein subunit of mitochondrial succinate dehydrogenase: The corresponding serum antibodies are good markers of an immune-mediated damage to the eye muscle in patients with Graves' hyperthyroidism
12. The cDNA sequence of the flavoprotein subunit of human heart succinate dehydrogenase
13. Soluble intercellular adhesion molecule-1 (sICAM-1) concentration in Graves' disease patients followed up for development of ophthalmopathy
14. Classification of eye changes of Graves' disease
15. The role of standardized echography in Graves' disease
16. Succinate dehydrogenase. I. Purification, molecular properties, and substructure
17. Reconstitufion of succinate dehydrogenase coenzyme Q reductase (complex II) and succinate oxidase activities by a highly purified, reactivated, succinate dehydrogenase
18. Structure and function of succinate dehydrogenase and fumarate reductase
19. Progress in succinate: Quinone oxidoreductase research
20. Studies on succinate dehydrogenase. XVI. Site of attachment of the covalently bound Flavin to the peptide chain
21. Arrangement of complex II (succinate-ubiquinone reductase) in the mitochondrial inner membrane
22. Evaluations of an enzyme-linked imunosorbent assay for the measurement of autoantibodies against eye muscle membrane antigens in Graves' ophthalmopathy
23. Eye muscle membrane reactive antibodies are not detected in the serum of immunoglobulin fraction of patients with thyroid-associated ophthalmopathy using an ELISA and crude membranes
24. The fibroblast is the target cell in the connective tissue manifestations of Graves' disease
25. Orbital connective tissue
26. Extrathyroidal manifestations of Graves' disease
27. Demonstration of circulating autoantibody against a soluble eye muscle antigen in Graves' ophthalmopathy
28. Pathogenesis of thyroid-associated ophthalmopathy; An autoimmune disorder of the eye muscle associated with Graves' hyperthyroidism and Hashimoto's thyroiditis
29. The lack of specificity of ophthalmic immunoglobulins in Graves' disease
30. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: Identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay
31. Immunoglobulin class and subclass distribution of eye muscle and fibroblast antibodies in patients with thyroid-associated ophthalmopathy
32. Role of eye muscle antibody measurement in the diagnosis of thyroid-associated ophthalmopathy: A laboratory update
33. Reevaluation of the prevalences of serum autoantibodies reactive with eye muscle antigens in patients with thyroid autoimmunity and ophthalmopathy
34. Endocrine ophthalmopathies. Problems of rational classification
35. Graves' immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured Graves' orbital fibroblasts
36. Elevated expression in situ of selectin and immunoglobulin superfamily type adhesion molecules in retroocular connective tissues from patients with Graves' ophthalmopathy
37. Behavior of soluble inter cellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma
38. Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue
39. Cloning and functional expression of a thyrotropin receptor cDNA from fat cells
40. Nuclear localization of auto antibodies. Novel insights into protein translocation and cellular function
41. Antibodies against succinate dehydrogenase and other skeletal muscle antigens in patients with ocular myasthenia gravis-possible mechanism for ocular muscle inflammation in acetylcholine receptor antibody negative patients
42. Relation of therapy for hyperthyroidism and the course of Graves' ophthalmopathy